{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-007758","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-10-09T21:25:16+00:00","discovered_at":"2026-10-09T21:26:00.892619+00:00","generated_at":"2026-10-12T14:57:43.226079+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sunshine Biopharma prices and closes $6.0M public offering, with up to $14.4M more if Series D warrants exercised","bullets":["On October 8, 2026, Sunshine Biopharma entered a placement agent agreement with Aegis Capital Corp. for a best-efforts public offering of Common Units and Pre-Funded Units.","The offering priced at $0.55 per Common Unit and $0.54999 per Pre-Funded Unit; gross proceeds were about $6.0 million before fees and expenses.","The offering included 10,509,082 Common Units and 400,000 Pre-Funded Units, each with two Series D warrants exercisable at $0.66 and expiring five years after issuance.","The closing occurred October 9, 2026; the Series D warrants could raise up to approximately $14.4 million if fully exercised for cash.","Aegis Capital Corp. received a 7% placement agent fee and a 1% non-accountable expense allowance; Sichenzia Ross Ference Carmel LLP and Kaufman & Canoles, P.C. acted as counsel."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-007758","json":"https://secwatch.observer/filing/0001683168-26-007758.json","markdown":"https://secwatch.observer/filing/0001683168-26-007758.md","text":"https://secwatch.observer/filing/0001683168-26-007758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826007758/0001683168-26-007758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826007758/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:57:43.226079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}